OneMedNet Business Summary

OneMedNet Corp (ONMD) operates as a specialized provider of regulatory-grade, AI-ready Real-World Data (RWD), primarily through its proprietary iRWD™ platform which connects a network of over 2,130 healthcare sites. The company is currently executing a strategic pivot from one-time, project-based data delivery to a high-margin recurring revenue model centered on its Palantir-powered Subscription Search and Subscription Data License offerings. These solutions provide life sciences companies and AI developers with near-real-time, multimodal data feeds for iterative model training and clinical trial feasibility. Beyond its core healthcare segment, OneMedNet leverages proprietary AI for data anonymization services in the finance and retail sectors. The company competes directly with specialized imaging data firms such as ScImage, Segmed, Harrison.ai, and TeleRay, positioning itself as a premium niche leader by offering longitudinal, regulatory-grade datasets that bridge the gap between raw clinical images and actionable real-world evidence. The leadership team is anchored by Founder, Chief Medical Officer, and Chairman Dr. Jeffrey Yu, a pioneer in clinical imaging innovation. Chief Executive Officer Aaron Green, appointed in early 2024, brings over 20 years of healthcare IT pedigree from senior roles at Optum Insights (VP of Cloud Solutions) and Change Healthcare. The executive suite is further supported by Chief Financial Officer Robert Golden, who oversees the company's recent balance sheet restructuring and Bitcoin-treasury strategy, and Chief Technology Officer James Wang, who leads the integration of agentic search and LLM capabilities. Notable institutional backing includes Off the Chain Capital, led by CIO Brian Estes, while the Board of Directors features industry veterans such as Dr. Kenneth Alleyne and Andrew Zeinfeld, providing deep expertise in medical technology and capital markets.